China Medical Imaging Equipment Market, Forecast to 2021

Policies, Disruption, and the Future of Medical Imaging
Share this:
Published: 13 Jul 2017

The study aims to analyze and forecast the healthcare imaging market in China (2017–2021). Research scope: Market trends, competitive structure, market metrics, market share, revenues, strategy, and government policies and initiatives. Regional scope: China (excluding Hong Kong) The study includes in-depth analysis of government-driven reforms, covering spending patterns, local manufacturers’ market situations, group purchasing practices, development of imaging centers, and public healthcare provision, from primary to tertiary care. Products covered include X-ray, ultrasound, CT, MRI, and nuclear imaging (PET/SPECT) systems. CT and MRI are becoming ubiquitous hospital items, with high market penetration and adoption. PET/SPECT remains niche, with slower growth. Various past practices have enabled favoritism across the country. The China government has taken this issue head-on in its development plan, changing regulations and purchasing channels, while also changing the landscape for both local and international brands, with each trying to establish and re-develop during the change. The study also highlights 11 key market themes and offers a glimpse into the future direction of the imaging market in China. It tracks the movement and investment direction by both public and private initiatives in the different regions of China, with emphasis on manufacturers, distributors, and public and private hospitals, as well as the differences between the different hospitals tiers and cities. It explores the historical context for why China is implementing the reforms and assesses the impact towards the strategy for affordable equipment, high-end imaging systems, integrated systems, selection routes on the different types and categories of medical imaging manufacturers, positioning, regulatory directions, and China’s approach toward Big Data, highlighting the drivers and priorities in the development platform, procurement, and manufacturing of healthcare imaging systems. This carries on into the models of operation and procurement. Lastly, it looks at what is required for imaging modalities to succeed and grow in the healthcare imaging market of China. This study uses both primary and secondary research to map out the landscape and changes that have affected the healthcare imaging market in China, measuring market share, revenues and growth from 2015 to 2020 (with data from 2014 where 2015’s was not yet available), providing insights for navigating the evolving market. Companies surveyed include Neusoft, Mindray, United Imaging, Wandong Medical Equipment, General Electric, Siemens, Philips, MILabs, IBA Labs, Basda Medical Apparatus, Landwind, Anke, Shanghai United Imaging,Heifei MT Medical, Perling, Mednova, CR Wandong, Aloka, Sonoscape, Besda, Xingaoyi, Liaoning Kampo, Shinva, and Agfa. Healthcare institutions covered include private hospitals, public Tier-I hospitals, Tier-II hospitals, Tier-III hospitals, township healthcare clinics, community healthcare centers, and village healthcare centers.



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..